BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in GlioblastomaYunzhan Li(China Pharmaceutical University), Inan Olmez(Virginia Commonwealth University)bioRxiv (Cold Spring Harbor Laboratory)December 29, 202510.64898/2025.12.28.696781Cited by 0SaveCiteExport RISWatch citationsRelated PapersTargeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha|Neuro-Oncology|2017|64Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition|Cancers|2024|7